Search

You searched for "PPE"

735 results found

Aspiration of anteriorly migrated dexamethasone implant using an 18G intravenous cannula

4 December 2025 | | EYE - Cornea, EYE - Vitreo-Retinal
Intravitreal dexamethasone (Ozurdex 0.7mg) is a biodegradable, sustained-release implant used to manage diabetic macular oedema, macular oedema secondary to retinal vein occlusion, and non-infectious posterior uveitis due to its anti-inflammatory effects and VEGF suppression [1]. While effective, the implant may...

Identifying life-threatening uveal melanoma: A directed application of general-purpose AI

2 April 2025 | | EYE - Imaging, EYE - Oncology
Uveal melanoma (UM) is a rare but aggressive eye cancer, affecting approximately six people per million annually [1]. Uveal melanoma arises in three locations: the choroid, ciliary body, and iris. As the most common primary intraocular malignancy in adults, UM...

Poppers retinopathy: What is it and how do we treat it?

2 June 2025 | | EYE - Vitreo-Retinal
Poppers retinopathy is a relatively unknown phenomenon which afflicts users of poppers but should be considered as a differential in sudden-onset or sub-acute visual acuity loss – particularly in patients with a history of recreational drug use. Raising awareness of...

My Top Five: Tips for organising and delivering a national ophthalmology educational series

2 October 2025 | | EYE - General
Organising a national teaching series is both deeply rewarding and surprisingly complex. It requires more than just good content – it demands a well-thought-out purpose, seamless logistics, strong communication and meaningful evaluation. Over the past year, I had the opportunity...

The Escape Room and gamification of ophthalmology teaching

3 April 2024 | | EYE - General
Recently, there has been an interesting development in medical education and its ‘gamification’. Educators are constantly looking for new ways to engage their students by adding a friendly element of competition, as evidenced by the great success of online education...

Artificial intelligence in glaucoma: Assessing applications instead of technology

5 October 2026 | | EYE - Glaucoma
Much is said about the potential of artificial intelligence (AI) to transform clinical practice, particularly with the advent of foundation models [1]. The newest models are ‘pretrained’ on text, image, tabular and other forms of data to produce architectures that...

Eye tests data shows only 5% of children aged five and under had an eye test in 2025

9 October 2026 | optometry, public health
Marking World Sight Day, new analysis of UK eye tests data estimates that only around 5% of the total population of children aged 5 years and under had an eye test in 2025, despite optometrists and opticians recommending that children...

My ophthalmology elective: Reflections from Singapore

4 August 2025 | | EYE - General
Why do an ophthalmology elective? An elective in ophthalmology can offer a unique opportunity to delve deeper into the highly competitive specialty beyond the confines of the medical school curriculum, while experiencing a healthcare system in a new cultural setting....

From paper to digital: Real lessons for a sustainable NHS digital future

19 February 2026 | | EYE - General
Portsmouth's OpenEyes implementation reveals why healthcare digital transformation needs honest evaluation, proper clinical leadership resourcing and realistic expectations about technology efficiency promises. Like many eye departments across the NHS, we at Portsmouth were drowning in paper. Notes went missing, handwriting...

Caring for adults with an ocular tumour

1 December 2015 | | EYE - Vitreo-Retinal
Detection If you screen for an intraocular tumour, dilate the pupil. If the patient is driving, use phenylephrine only. If the patient declines, document this in the casenotes. Don’t forget to look for sentinel vessels, which would indicate a ciliary...

A closer look at the new wave of glaucoma surgery – radical or old school?

1 October 2016 | | EYE - Glaucoma
Glaucoma is a challenging condition to treat because the exact pathophysiology remains unclear and the only readily modifiable factor is the intraocular pressure (IOP). Additionally, most glaucoma patients are completely asymptomatic, yet are often subjected to lifelong medical therapy. The...

Contemporary glaucoma therapy: spoilt for choice

1 April 2014 | | EYE - Glaucoma
The goal of glaucoma management is to prevent visual loss and disease progression in the patient’s lifetime through effective lowering of intraocular pressure (IOP), the primary modifiable risk factor in glaucoma. Sustained and consistent IOP reduction is key to halting...